Tff Pharmaceuticals Inc Revenue Growth Rates (TFFP), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Tff Pharmaceuticals Inc  (NASDAQ: TFFP)
 

TFFP's Revenue Growth by Quarter and Year

Tff Pharmaceuticals Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TFFP Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December -
3rd Quarter September 0.19
2nd Quarter June 0.65
1st Quarter March 0.20
FY 1.04





TFFP Revenue third quarter 2024 Y/Y Growth Comment
Tff Pharmaceuticals Inc reported decline in Revenue in the third quarter 2024 by -15.92% to $ 0.19 millions, from the same quarter in 2023.
The contraction in the third quarter 2024 Tff Pharmaceuticals Inc's Revenue compares unfavorably to the Company's average Revenue doubling of 466.15%.

Looking into third quarter 2024 results within Major Pharmaceutical Preparations industry 32 other companies have achieved higher Revenue growth. While Tff Pharmaceuticals Inc' s Revenue fall of -15.92% ranks overall at the positon no. 173 in the third quarter 2024.


TFFP Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December - -64.52 % 3000 % -
3rd Quarter September -15.92 % 155.56 % 80 % -
2nd Quarter June 96.97 % 1000 % - -
1st Quarter March 300 % -28.57 % 250 % -
FY   - 44 % 525 % -

Financial Statements
Tff Pharmaceuticals Inc's third quarter 2024 Revenue $ 0.19 millions TFFP's Income Statement
Tff Pharmaceuticals Inc's third quarter 2023 Revenue $ 0.23 millions Quarterly TFFP's Income Statement


TFFP Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - -52.17 % 244.44 % -80 %
3rd Quarter September -70.25 % -30.3 % 200 % -
2nd Quarter June 225 % 560 % -57.14 % -
1st Quarter March 81.82 % -83.87 % 600 % -
FY (Year on Year)   - 44 % 525 % -


Back to TFFP Growth rate Comparisons >> Back to TFFP Growth rate Comparisons >>


Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #33
Healthcare Sector #61
Overall #173

Revenue Y/Y Growth Statistics
High Average Low
1031.68 % 466.15 % 67.94 %
(Jun 30 2023)   (Sep 30 2024)
Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #33
Healthcare Sector #61
Overall #173
Revenue Y/Y Growth Statistics
High Average Low
1031.68 % 466.15 % 67.94 %
(Jun 30 2023)   (Sep 30 2024)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Tff Pharmaceuticals Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
2602.7 % 446.73 % -85.32 %
(Sep 30 2021)  


TFFP's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2024 Tff Pharmaceuticals Inc disclosed fall in Revenue from the second quarter by -70.25% to $ 0.19 millions, from $ 0.65 millions achived in the previous reporting period.

But that's not important problem, as Tff Pharmaceuticals Inc's Revenue generally seem to plunge in this quarter.

Within Major Pharmaceutical Preparations industry 201 other companies have achieved higher Revenue quarter on quarter growth. While Tff Pharmaceuticals Inc's Revenue growth quarter on quarter, overall rank is 3212.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #202
Healthcare Sector #516
Overall #3212
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #202
Healthcare Sector #516
Overall #3212
Revenue Q/Q Growth Statistics
High Average Low
2602.7 % 446.73 % -85.32 %
(Sep 30 2021)  


TFFP's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2024 Tff Pharmaceuticals Inc disclosed fall in Revenue from the second quarter by -70.25% to $ 0.19 millions, from $ 0.65 millions achived in the previous reporting period.

But that's not important problem, as Tff Pharmaceuticals Inc's Revenue generally seem to plunge in this quarter.

Within Major Pharmaceutical Preparations industry 201 other companies have achieved higher Revenue quarter on quarter growth. While Tff Pharmaceuticals Inc's Revenue growth quarter on quarter, overall rank is 3212.


Tff Pharmaceuticals Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)
Cumulative Revenue 12 Months Ending $ 1.16 $ 1.20 $ 0.89 $ 0.73 $ 0.93
Y / Y Revenue Growth (TTM) 24.55 % 53.16 % 84.6 % 48.01 % 377.98 %
Year on Year Revenue Growth Overall Ranking # 11 # 5 # 0 # 30 # 19
Seqeuential Revenue Change (TTM) -3.44 % 35.78 % 20.69 % -21.29 % 18.74 %
Seq. Revenue Growth (TTM) Overall Ranking # 173 # 18 # 0 # 473 # 574


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2024 period, Tff Pharmaceuticals Inc's cumulative twelve months Revenue were $ 1 millions, company would post below average annual Revenue growth of 18.74% year on year, if the fiscal year would end at Sep 30 2024.
A slow-down in the Tff Pharmaceuticals Inc's Revenue growth from the 0.65% growth in Jun 30 2024.

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 5 to 11.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 33
Healthcare Sector # 5
Overall # 11

Revenue TTM Y/Y Growth Statistics
High Average Low
1031.68 %
 466.15 %
67.94 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 33
Sector # 61
S&P 500 # 173
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2024 period, Tff Pharmaceuticals Inc's cumulative twelve months Revenue were $ 1 millions, company would post below average annual Revenue growth of 67.94% year on year, if the fiscal year would end at Sep 30 2024.
A slow-down in the Tff Pharmaceuticals Inc's Revenue growth from the 0.65% growth in Jun 30 2024.

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 5 to 11.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 33
Healthcare Sector # 5
Overall # 11

Revenue TTM Y/Y Growth Statistics
High Average Low
1031.68 %
466.15 %
67.94 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 33
Sector # 61
S&P 500 # 173




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TFFP's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Sep 30 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2024
West Pharmaceutical Services Inc -0.08%$ -0.080 millions
Nektar Therapeutics-0.08%$ -0.083 millions
Apyx Medical Corp-0.22%$ -0.219 millions
Avantor Inc -0.34%$ -0.337 millions
Avanos Medical Inc -0.35%$ -0.352 millions
Integra Lifesciences Holdings Corp-0.41%$ -0.415 millions
Nuwellis Inc -0.59%$ -0.588 millions
Alkermes Plc -0.73%$ -0.734 millions
Prestige Consumer Healthcare Inc -0.92%$ -0.922 millions
Psychemedics Corporation-1.02%$ -1.021 millions
Petros Pharmaceuticals inc -1.34%$ -1.342 millions
10x Genomics Inc -1.39%$ -1.391 millions
Abcellera Biologics Inc -1.39%$ -1.394 millions
Nephros Inc -1.41%$ -1.409 millions
Charles River Laboratories International inc -1.64%$ -1.642 millions
Inspiremd Inc -1.67%$ -1.669 millions
Cv Sciences Inc -1.69%$ -1.691 millions
Elutia Inc -1.71%$ -1.712 millions
Enhabit Inc -1.82%$ -1.820 millions
Accuray Incorporated-1.96%$ -1.956 millions
Zimvie Inc -1.98%$ -1.984 millions
Reflect Scientific Inc-2.25%$ -2.254 millions
Upstream Bio Inc -2.25%$ -2.254 millions
Maravai Lifesciences Holdings Inc -2.49%$ -2.490 millions
Biogen Inc -2.55%$ -2.549 millions
Fresenius Medical Care Ag-2.66%$ -2.658 millions
Opko Health Inc -2.78%$ -2.779 millions
Precision Optics Corporation Inc -2.87%$ -2.874 millions
Msa Safety Inc-2.98%$ -2.985 millions
Teladoc Health Inc -2.99%$ -2.988 millions


About Tff Pharmaceuticals Inc Revenue Growth Rates (TFFP), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Tff Pharmaceuticals Inc (CIK 1733413).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001213900-24-100587
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Tff Pharmaceuticals Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.